Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VectorB2B is a Portuguese Collaborative Laboratory (CoLAB) that operates as a full-service Contract Research Organization (CRO) specializing in drug discovery and development. It provides an integrated "one-stop-shop" approach, offering services that span from initial drug discovery and medicinal chemistry to pre-clinical safety assessments and Phase I/II clinical trial management. The association leverages a consortium of leading Portuguese academic institutions and industrial partners to accelerate the translation of scientific research into clinical applications. VectorB2B supports clients with regulatory affairs, CMC (Chemistry, Manufacturing, and Controls), and project management across various therapeutic modalities, including small molecules and biologics. Its mission is to bridge the gap between academic research and the pharmaceutical industry by providing highly specialized technical and scientific support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VectorB2B.